Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04003623
Title Efficacy and Safety of Pemigatinib in Participants With Solid Tumors With FGFR Mutations or Translocations (FIGHT-208)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Incyte Corporation
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Compassionate Cancer Care Medical Group Fountain Valley California 92708 United States Details
Ocala Oncology Center Ocala Florida 34474 United States Details
Hawaii Cancer Care Honolulu Hawaii 96813 United States Details
Illinois Cancer Care Peoria Illinois 61615 United States Details
FMH James M Stockman Cancer Institute Frederick Maryland 21702 United States Details
New Jersey Cancer Care and Blood Disorders Belleville New Jersey 07109 United States Details
TriHealth Cincinnati Ohio 45220 United States Details
Sanford Cancer Center Sioux Falls South Dakota 51704 United States Details
Mary Crowley Cancer Center Dallas Texas 75230 United States Details
Oncology Consultants Houston Texas 77030 United States Details
Utah Cancer Specialists Salt Lake City Utah 84106 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field